Nagi Bioscience aims to revolutionize the way toxic and/or beneficial effects of substances are tested.
nagi bioscience has raised €1.7M across 1 funding round, most recently a Seed round in Oct 2019. Based in Lausanne, Switzerland; founded 2019; active in Healthtech. Data as of 7 Aug 2026.
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2019-10-01 | Seed | €1.7M |
| — |
| View deal → |
